EFFECT OF ANTAGONISTS OF PLATELET-ACTIVATING-FACTOR RECEPTORS ON MEMORY OF INHIBITORY AVOIDANCE IN RATS

被引:26
|
作者
JERUSALINSKY, D [1 ]
FIN, C [1 ]
QUILLFELDT, JA [1 ]
FERREIRA, MBC [1 ]
SCHMITZ, PK [1 ]
DASILVA, RC [1 ]
WALZ, R [1 ]
BAZAN, NG [1 ]
MEDINA, JH [1 ]
IZQUIERDO, I [1 ]
机构
[1] UFRGS CTR,INST BIOCIENCIAS,DEPT BIOQUIM,CTR MEMORIA,BR-90046900 PORTO ALEGRE,RS,BRAZIL
来源
BEHAVIORAL AND NEURAL BIOLOGY | 1994年 / 62卷 / 01期
关键词
D O I
10.1016/S0163-1047(05)80052-4
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Platelet-activating factor (PAF) is present in the brain. It enhances glutamate release and long-term potentiation (LTP) through an action on synaptic membrane receptors sensitive to the antagonist, BN 52021, and has been proposed as a retrograde messenger in the genesis of LTP. In addition, PAF has other, metabolic actions mediated by microsomal receptors sensitive to the antagonist, BN 50730. We investigated the effect on memory of the pre- or post-training infusion of BN 52021 or BN 50730 into the hippocampus and that of BN 52021 in the amygdala and the entorhinal cortex. Male Wistar rats were implanted bilaterally with cannulae aimed at these brain regions. After recovery from surgery, the animals were trained in step-down inhibitory avoidance using a 0.5-mA foot shock and tested for retention 24 h later. BN 52021 (0.5 mu g/side) was amnestic when given into the hippocampus or the amygdala either before or immediately after training but not 30 or 100 min later. BN 52021 was also amnestic when given into the entorhinal cortex 100 but not 0 or 300 min after training. Intrahippocampally administered BN 50730 had no effect on memory. The findings are compatible with the suggestion from previous findings that memory of this task depends on the generation of LTP at the time of training in hippocampus and amygdala and, 90-180 min later, in the entorhinal cortex. (C) 1994 Academic Press, Inc.
引用
收藏
页码:1 / 3
页数:3
相关论文
共 50 条
  • [31] EFFECT OF SENNA IS NOT MEDIATED BY PLATELET-ACTIVATING-FACTOR
    CAPASSO, F
    IZZO, AA
    MASCOLO, N
    AUTORE, G
    DICARLO, G
    PHARMACOLOGY, 1993, 47 : 58 - 63
  • [32] EFFECT OF AZELASTINE ON PLATELET-ACTIVATING-FACTOR AND ANTIGEN-INDUCED PLEURISY IN RATS
    LIMA, MCR
    MARTINS, MA
    PEREZ, SAC
    SILVA, PMR
    CORDEIRO, RSB
    VARGAFTIG, BB
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 197 (2-3) : 201 - 207
  • [33] EFFECT OF PLATELET-ACTIVATING-FACTOR AND TUMOR-NECROSIS-FACTOR ON NEUTROPHIL RECEPTORS, BINDING AND PHAGOCYTOSIS
    OGLE, J
    NOEL, J
    OGLE, C
    SOLOMKIN, J
    ALEXANDER, JW
    JOURNAL OF LEUKOCYTE BIOLOGY, 1987, 42 (05) : 562 - 562
  • [34] IDENTIFICATION OF FUNCTIONAL PLATELET-ACTIVATING-FACTOR RECEPTORS ON HUMAN KERATINOCYTES
    TRAVERS, JB
    HUFF, JC
    ROLAPLESZCZYNSKI, M
    GELFAND, EW
    MORELLI, JG
    MURPHY, RC
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1995, 105 (06) : 816 - 823
  • [35] KADSURENONE AND OTHER RELATED LIGNANS AS ANTAGONISTS OF PLATELET-ACTIVATING-FACTOR RECEPTOR
    SHEN, TY
    HUSSAINI, IM
    METHODS IN ENZYMOLOGY, 1990, 187 : 446 - 455
  • [36] EFFECT OF A PLATELET-ACTIVATING-FACTOR ANTAGONIST AND ANTITHROMBIN III ON SEPTICEMIA AND ENDOTOXEMIA IN RATS
    INOUE, Y
    KOHNO, S
    MIYAZAKI, T
    YAMAGUCHI, K
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 163 (03): : 175 - 185
  • [38] CYCLIC ETHER ACETAL PLATELET-ACTIVATING-FACTOR (PAF) RECEPTOR ANTAGONISTS
    BOWLES, SA
    BEBBINGTON, DS
    CACKETT, KS
    CHRISTODOULOU, MS
    DAVIDSON, AH
    FLOYD, CD
    MILLER, A
    PRATT, LM
    SAROGLOU, L
    SPAVOLD, ZM
    THOMPSON, TM
    TIMMIS, DJ
    WHITTAKER, M
    WOOD, LM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1993, 206 : 212 - MEDI
  • [39] SPECIES-DIFFERENCE IN THE SPECIFIC RECEPTORS OF PLATELET-ACTIVATING-FACTOR
    HWANG, SB
    LAM, MH
    BIOCHEMICAL PHARMACOLOGY, 1986, 35 (24) : 4511 - 4518
  • [40] STRUCTURE ACTIVITY STUDIES ON TRIAZOLOTHIENODIAZEPINE DERIVATIVES AS PLATELET-ACTIVATING-FACTOR ANTAGONISTS
    MIYAZAWA, S
    OKANO, K
    SHIMOMURA, N
    CLARK, RSJ
    KAWAHARA, T
    ASANO, O
    YOSHIMURA, H
    MIYAMOTO, M
    SAKUMA, Y
    MURAMOTO, K
    OBAISHI, H
    HARADA, K
    KAJIMA, T
    YAMADA, K
    TSUNODA, H
    KATAYAMA, S
    ABE, S
    ASAKAWA, N
    SOUDA, S
    HORIE, T
    SATO, T
    MACHIDA, Y
    KATAYAMA, K
    YAMATSU, I
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1991, 39 (12) : 3215 - 3220